TELK Key Stats
- TELIK INC Files SEC form 8-K, Change in Directors or Principal Officers, Submiss... May 20
- Telik Announces First Quarter 2013 Financial Results PR Newswire May 10
- TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Fin... May 10
- Telik: A Possible Investment, But Only After Much Consideration Apr 5
- TELIK INC Files SEC form 8-K, Results of Operations and Financial Condition, Fin... Mar 15
- Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Fina... Mar 15
- TELIK INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financ... Mar 5
- TELIK INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Fi... Feb 22
- Is There Value In Telik? Jan 24
- 4 Healthcare Stock Stories for Wednesday Wellness Jan 23
TELK Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Telik is down 69.52% over the last year vs S&P 500 Total Return up 28.03%, Acura Pharmaceuticals down 18.06%, and Horizon Pharma down 37.11%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for TELK
Pro Report PDF for TELK
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download TELK Pro Report PDF
Pro Strategies Featuring TELK
Did Telik make it into our Pro Portfolio Strategies?